Published in Clin Exp Hypertens on February 10, 2005
Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial. J Med Internet Res (2007) 5.79
Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation (2011) 1.15
Gout, diuretics and the kidney. Ann Rheum Dis (2006) 1.02
Quality and effectiveness of different approaches to primary care delivery in Brazil. BMC Health Serv Res (2006) 1.01
Fruit and vegetable consumption and proinflammatory gene expression from peripheral blood mononuclear cells in young adults: a translational study. Nutr Metab (Lond) (2010) 0.96
Dietary total antioxidant capacity is inversely related to central adiposity as well as to metabolic and oxidative stress markers in healthy young adults. Nutr Metab (Lond) (2011) 0.89
Physical activity and cardiovascular disease risk factors among young and middle-aged men in urban Mwanza, Tanzania. Pan Afr Med J (2012) 0.87
New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol (2008) 0.82
Reduction of C-reactive protein and the use of anti-hypertensives. Vasc Health Risk Manag (2007) 0.82
Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption. Int J Mol Sci (2013) 0.82
Assessment of Risk Factors for Development of Type-II Diabetes Mellitus Among Working Women in Berhampur, Orissa. Indian J Community Med (2009) 0.81
Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries: A Systematic Review. Hypertension (2016) 0.80
Vitamin D Deficiency in Uygurs and Kazaks Is Associated with Polymorphisms in CYP2R1 and DHCR7/NADSYN1 Genes. Med Sci Monit (2015) 0.80
Contribution of gender and body fat distribution to inflammatory marker concentrations in apparently healthy young adults. Inflamm Res (2012) 0.79
Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature. J Cell Mol Med (2010) 0.79
Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet. EXCLI J (2014) 0.79
LINE-1 methylation is positively associated with healthier lifestyle but inversely related to body fat mass in healthy young individuals. Epigenetics (2016) 0.77
Different postprandial acute response in healthy subjects to three strawberry jams varying in carbohydrate and antioxidant content: a randomized, crossover trial. Eur J Nutr (2013) 0.77
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination. Integr Blood Press Control (2010) 0.76
Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor? Curr Cardiol Rev (2008) 0.75
The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens (2016) 0.75
DNA hypermethylation of the serotonin receptor type-2A gene is associated with a worse response to a weight loss intervention in subjects with metabolic syndrome. Nutrients (2014) 0.75
Mitochondrial respiratory dysfunctions of blood mononuclear cells link with cardiac disturbance in patients with early-stage heart failure. Sci Rep (2015) 0.75
The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension. Ghana Med J (2013) 0.75
Implementation of a Screening Program for Patients at Risk for Posttraumatic Stress Disorder. Clin Med Insights Cardiol (2016) 0.75
An association of platelet indices with blood pressure in Beijing adults: Applying quadratic inference function for a longitudinal study. Medicine (Baltimore) (2016) 0.75
Left ventricular relative wall thickness versus left ventricular mass index in non-cardioembolic stroke patients. Medicine (Baltimore) (2015) 0.75
Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies. Toxicol Sci (2016) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Severe hypoglycemia and risks of vascular events and death. N Engl J Med (2010) 8.54
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol (2008) 5.40
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation (2008) 4.29
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med (2014) 3.81
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med (2005) 3.44
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J (2008) 2.41
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37
Red cell distribution width and coronary artery bypass surgery. Eur J Cardiothorac Surg (2012) 2.32
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care (2013) 2.07
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension (2011) 1.89
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89
The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med (2008) 1.83
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J (2009) 1.79
Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension (2010) 1.78
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. J Am Coll Cardiol (2010) 1.74
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med (2012) 1.69
Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68
Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). Stroke (2009) 1.64
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int (2012) 1.63
UKPDS and the legacy effect. N Engl J Med (2008) 1.49
Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. Eur Heart J (2005) 1.46
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke (2009) 1.43
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertens (2011) 1.41
Oesophageal perforation complicating intraoperative transoesophageal echocardiography: suspicion can save lives. Interact Cardiovasc Thorac Surg (2010) 1.39
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. Eur Heart J (2010) 1.34
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation (2013) 1.32
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. J Am Soc Nephrol (2007) 1.31
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke (2009) 1.27
Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis (2008) 1.22
Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension (2009) 1.22
The PROGRESS trial three years later: time for more action, less distraction. BMJ (2004) 1.20
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2005) 1.20
Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke (2008) 1.17
Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in Australia. BMJ Open (2014) 1.16
Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. Eur J Cardiovasc Prev Rehabil (2011) 1.15
International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens (2003) 1.14
Sampling time error in EuroSCORE II. Interact Cardiovasc Thorac Surg (2012) 1.13
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med (2012) 1.12
Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med (2004) 1.11
Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis. PLoS Med (2010) 1.09
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke (2005) 1.07
Statins and long-term survival after isolated valve surgery: the importance of valve type, position and procedure. Eur J Cardiothorac Surg (2013) 1.06
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol (2010) 1.04
International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens (2003) 1.02
In-hospital mortality and long-term survival after coronary artery bypass surgery in young patients. Eur J Cardiothorac Surg (2012) 1.00
Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis (2012) 0.99
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia (2014) 0.99
Long-term survival after coronary artery bypass surgery stratified by EuroSCORE. Eur J Cardiothorac Surg (2012) 0.98
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension (2003) 0.96
All hats off to ALLHAT: a massive study with clear messages. J Hypertens (2003) 0.96
The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion. Int J Behav Nutr Phys Act (2014) 0.96
Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes Care (2012) 0.95
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. Eur Heart J (2010) 0.94
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes (2013) 0.92
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J Am Heart Assoc (2012) 0.92
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil (2011) 0.91
Is single-unit blood transfusion bad post-coronary artery bypass surgery? Interact Cardiovasc Thorac Surg (2013) 0.91
Mortality patterns in hypertension. J Hypertens (2011) 0.90
Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg (2012) 0.90
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial. Stroke (2006) 0.88
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. J Hypertens (2010) 0.86
Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia. BMC Public Health (2014) 0.82
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. Diabetes Care (2014) 0.82
Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage? J Hypertens (2002) 0.81
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals. J Hypertens (2011) 0.81
Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice. Int J Stroke (2011) 0.81
Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial. Stroke (2012) 0.81
Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLoS One (2013) 0.81
Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke. Stroke (2013) 0.80
Debating evidence for the origin of life on Earth. Science (2007) 0.80
Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage. Cerebrovasc Dis (2015) 0.80
Diuretics: a modern day treatment option? Nephrology (Carlton) (2006) 0.79
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality? Cancer Epidemiol Biomarkers Prev (2013) 0.79
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. J Hypertens (2004) 0.79
Is a blood pressure target of <130/80 mm Hg still appropriate for high-risk patients? Circulation (2011) 0.79
The risk of cancer in people with diabetes and chronic kidney disease. Nephrol Dial Transplant (2012) 0.79
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. J Hypertens (2010) 0.79
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial. Hypertension (2010) 0.79
PROGRESS: Prevention of Recurrent Stroke. J Clin Hypertens (Greenwich) (2011) 0.78
Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2. Stroke (2013) 0.78
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. Eur J Health Econ (2008) 0.78
The ABCD of anti-hypertensive therapy? J Hypertens (2002) 0.78
Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke (2012) 0.78